Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer02:18

Cancer

55.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
3.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SEPAR-SECT recommendations for perioperative invasive mediastinal staging of non-small cell lung cancer.

Cirugia espanola·2026
Same author

Progress in Thymic Malignancy Care: The Imperative for Global Standards and Collaboration.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

SEPAR-SECT Recommendations for Perioperative Invasive Mediastinal Staging of Non-small Cell Lung Cancer.

Archivos de bronconeumologia·2026
Same author

A Response to the Letter to the Editor: "Is It Time to Move Beyond Linear Measurements Toward Volumetric Assessment in Thymic Tumors?"

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy.

The Journal of thoracic and cardiovascular surgery·2026
Same author

ASO Visual Abstract: Systematic endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) compared with targeted EBUS-TBNA for mediastinal staging of locally advanced non-small-cell lung cancer.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Mar 21, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

1.4K

Striving for an Enhanced Tumor Classification System: Reflections on Cancer, Prognosis, Human Nature and Reality.

Frank Detterbeck1, Ramon Rami-Porta2

  • 1Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT.

Clinical Lung Cancer
|March 19, 2026
PubMed
Summary

Lung cancer staging (TNM) needs enhancement to include prognostic factors for better patient outcome prediction. This study clarifies TNM, prognosis, and the need for improved predictive accuracy in clinical practice.

Keywords:
BiomarkersLung cancerPredictive factorsPrognostic factorsSurvival

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

1.4K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.4K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Area of Science:

  • Oncology
  • Clinical Decision-Making
  • Cancer Staging

Background:

  • The TNM classification is central to lung cancer patient care.
  • Modern treatments blend local and systemic therapies, necessitating improved prognostic tools.
  • There is a growing demand for an "enhanced TNM" system incorporating additional predictive factors.

Purpose of the Study:

  • To contribute to the discussion on enhancing the TNM classification for lung cancer.
  • To clarify the current TNM system, its prognostic implications, and the concept of "enhanced TNM".

Main Methods:

  • Literature review and conceptual analysis of TNM classification.
  • Exploration of prognostic factors in lung cancer.
  • Discussion of clinical decision-making needs in oncology.

Main Results:

  • The TNM system defines anatomic tumor extent but lacks comprehensive prognostic detail.
  • An "enhanced TNM" aims to integrate prognostic factors for more accurate patient outcome prediction.
  • Understanding the nuances of prognostic prediction is crucial for clinical utility.

Conclusions:

  • The TNM classification requires augmentation with prognostic factors to better guide lung cancer treatment.
  • A clearer definition of "enhanced TNM" is needed for practical clinical application.
  • Further discussion is essential to develop a clinically useful prognostic prediction model for lung cancer.